Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Mar 25;6(4):359-361.
doi: 10.1016/j.jdcr.2020.01.028. eCollection 2020 Apr.

Propranolol-induced hyperkalemia in the management of infantile hemangioma

Affiliations
Case Reports

Propranolol-induced hyperkalemia in the management of infantile hemangioma

Huda Al-Rwebah et al. JAAD Case Rep. .
No abstract available

Keywords: atenolol; hemangioma; hyperkalemia; propranolol; β-blocker.

PubMed Disclaimer

Figures

Fig 1
Fig 1
A, Ulcerated infantile hemangioma measuring 5 × 6 cm on the upper portion of the chest before treatment. B, Infantile hemangioma completely resolved with only a scar 6 months after initiation of atenolol therapy.

References

    1. Drolet B.A., Esterly N.B., Frieden I.J. Hemangiomas in children. N Engl J Med. 1999;34:173–181. - PubMed
    1. Léauté-Labrèze C., De la Roque E.D., Hubiche T. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358:2649–2651. - PubMed
    1. Fabre Pierre. Pierre Fabre obtains FDA approval to market Hemangeol for the treatment of infantile hemangioma. http://www.pierre-fabre.com/en/fda-approval-market-hemangeoltm Available at:
    1. Léaute-Labrèze C., Boccara O., Degrugillier-Chopinet C. Safety of oral propranolol for the treatment of infantile hemangioma: a systematic review. Pediatrics. 2016;138(4) e20160353. - PubMed
    1. Pavlakovic H., Kietz S., Lauerer P. Hyperkalemia complicating propranolol treatment of an infantile hemangioma. Pediatrics. 2010;126:e1589–e1593. - PubMed

Publication types

LinkOut - more resources